Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Glyn Edwards takes helm at Summit with fresh finances planned

This article was originally published in Scrip

Executive Summary

Antisoma's former CEO Glyn Edwards is a busy man. The interim CEO of the UK BioIndustry Association (BIA) has just accepted a third executive leadership position, this time as CEO of Summit, following on from his recent appointment as CEO of the Oxford University-linked cancer biomarker firm, Oxford Cancer Biomarkers (scripintelligence.com, 18 January 2012).

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC016870

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel